Viridian Therapeutics Stock Forecast

Hold candidate since Jun 03, 2026

The Viridian Therapeutics, Inc. stock price gained 3.02% on the last trading day (Wednesday, 3rd Jun 2026), rising from $15.87 to $16.35. During the last trading day the stock fluctuated 4.13% from a day low at $15.75 to a day high of $16.40. The price has risen in 6 of the last 10 days and is up by 2.38% over the past 2 weeks. Volume fell on the last day by -376 thousand shares and in total, 2 million shares were bought and sold for approximately $26.80 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $14.22, a level that may pose a second chance to hit a runner. According to fan-theory $20.58 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

VRDN Signals & Forecast

The Viridian Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $16.93. On a fall, the stock will find some support from the long-term average at approximately $15.87. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 05, 2026, and so far it has fallen -12.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Viridian Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $14.47 and $13.96. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Viridian Therapeutics, Inc. finds support just below today's level at $14.47. If this is broken, then the next support from accumulated volume will be at $13.96 and $13.90.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.650 between high and low, or 4.13%. For the last week, the stock has had daily average volatility of 4.07%.

Our recommended stop-loss: $15.76 (-3.60%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 20 days ago.)

Trading Expectations (VRDN) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Viridian Therapeutics, Inc. to open at $16.17, and during the day (based on 14 day Average True Range), to move between $15.88 and $16.82, which gives a possible trading interval of +/-$0.94 (+/-5.93%) up or down from last closing price. If Viridian Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.97 (3.79%) than the support at $14.47 (11.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Viridian Therapeutics, Inc. stock A Buy?

Viridian Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.355 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $16.17 ( 1.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk